Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.38 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALPG | P10696 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16789303 | 0.85 | KDM4E (0.45) | L3MBTL1KDM4EATMMAPK1KMT2A | |
| SCHEMBL17077087 | 0.81 | KDM4E (0.46) | L3MBTL1KDM4EATMMAPK1KMT2A | |
| SCHEMBL15741195 | 0.80 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMKMT2ASMN1; SMN2 | |
| SCHEMBL2682396 | 0.80 | KDM4E (0.39) | L3MBTL1KDM4EATMMAPK1KMT2A | |
| SCHEMBL17077097 | 0.77 | KDM4E (0.46) | L3MBTL1KDM4EATMMAPK1KMT2A | |
| Benzene SCHEMBL28486033 | 0.77 | L3MBTL1 (1.00) | L3MBTL1KDM4EATMMAPK1KMT2A | |
| SCHEMBL31962 | 0.77 | L3MBTL1 (1.00) | L3MBTL1KDM4EATMMAPK1KMT2A | |
| SCHEMBL29358118 | 0.77 | L3MBTL1 (1.00) | L3MBTL1KDM4EATMMAPK1KMT2A | |
| SCHEMBL15616867 | 0.76 | KDM4E (0.45) | L3MBTL1KDM4EATMKMT2AALDH1A1 | |
| SCHEMBL28656369 | 0.75 | L3MBTL1 (0.95) | L3MBTL1KDM4EATMMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651397-B2 | Organic light emitting compound and organic light emitting device comprising the same | SFC CO., LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20160248024-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SFC CO., LTD. (KR) | 2016-08-25 | — | — | US | disclosed |
| US-20160248024-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SFC CO., LTD. (KR) | 2016-08-25 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10651397-B2 | Organic light emitting compound and organic light emitting device comprising the same | MAP1LC3C, CRY1, MAP1LC3A | L3MBTL1 213/4885KDM4E 2510/4885ATM 2473/4885 |
| US-20160248024-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | MAP1LC3C, CRY1, MAP1LC3A | L3MBTL1 213/4885KDM4E 2510/4885ATM 2473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.